Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters.

J H Check, J S Chase, K Nowroozi

    International Journal of Fertility
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
    Same author

    Fabrication and characterization of high-T(c) YBa(2)Cu(3)O(7-x) nanoSQUIDs made by focused ion beam milling.

    Nanotechnology·2011
    Same author

    Thigh muscle volume predicted by anthropometric measurements and correlated with physical function in the older adults.

    The journal of nutrition, health & aging·2011
    Same author

    Effects of operational parameters on decolorisation of C.I. Reactive Black 5 in UV/TiO(2) system.

    Water science and technology : a journal of the International Association on Water Pollution Research·2011
    Same author

    cDNA cloning by inverse polymerase chain reaction.

    Methods in molecular biology (Clifton, N.J.)·2011
    Same author

    Progress toward a synthetic virus : a multicomponent system for liver-directed DNA delivery.

    Methods in molecular medicine·2011
    Same journal

    Confidentiality and American semen donors.

    International journal of fertility·1993
    Same journal

    Trichosanthin as an abortifacient for terminating early pregnancy in mice.

    International journal of fertility·1993
    Same journal

    Hormonal and immunologic methods in the diagnosis and treatment of patients with benign ovarian tumors and endometriotic cysts.

    International journal of fertility·1993
    Same journal

    A decade of experience with transdermal estrogen replacement therapy: overview of key pharmacologic and clinical findings.

    International journal of fertility·1993
    Same journal

    Homologous artificial insemination (AIH) and gamete intrafallopian transfer (GIFT) in Roman Catholicism and Halakhic Judaism.

    International journal of fertility·1993
    Same journal

    Auto-immunity to spermatozoa and quality of semen in men with spinal cord injury.

    International journal of fertility·1993
    See all related articles

    Prophylactic progesterone vaginal suppositories (PVS) significantly reduced spontaneous abortion risk in high-risk women. This treatment shows promise for preventing pregnancy loss in women with a history of recurrent miscarriages.

    Area of Science:

    • Reproductive Medicine
    • Obstetrics
    • Pharmacology

    Background:

    • Recurrent spontaneous abortion (RSA) poses a significant risk to women with a history of pregnancy loss.
    • Effective interventions to prevent spontaneous abortions in high-risk populations are crucial.

    Purpose of the Study:

    • To evaluate the efficacy of prophylactic progesterone vaginal suppositories (PVS) in reducing the risk of spontaneous abortions.
    • To assess the impact of PVS on pregnancy outcomes in women with a history of at least one prior spontaneous abortion.

    Main Methods:

    • A study involving women with a history of spontaneous abortion.
    • Prophylactic progesterone vaginal suppositories (PVS) administered during the luteal phase until the end of the first trimester.
    • Dosage adjusted based on endometrial biopsy and pregnancy status, with initial dose of 50 mg/day.

    Related Experiment Videos

    Main Results:

    • Only 10% of women using PVS experienced abortion.
    • Overall pregnancy loss rate was 9% (12/132) in PVS-treated patients.
    • Untreated controls had a significantly higher abortion rate of 42% (10/24).

    Conclusions:

    • Prophylactic progesterone vaginal suppositories (PVS) demonstrate effectiveness in reducing spontaneous abortion risk.
    • PVS is a viable treatment option for high-risk patients aiming to prevent pregnancy loss.
    • Further research may explore optimal PVS dosing and long-term outcomes.